Skip to main content
Clinical Trials/JPRN-UMIN000046307
JPRN-UMIN000046307Completed未知

Impact of COVID-19 pandemic on cancer diagnosis, treatment, and death in Japan: national-level registration study. - Impact of COVID-19 pandemic on cancer diagnosis, treatment, and death in Japan: national-level registration study.

Yokohama City University Hospital0 sites523,000 target enrollmentStarted: December 7, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
523,000

Study Overview

Brief Summary

See below: Horita N, Chen H, Fukumoto T. Impact of the COVID-19 Pandemic on Cancer Treatment: Nationwide Japanese Registration until 2021. J Am Coll Surg. 2023 Aug 1;237(2):380-381. PMID: 37070756 Horita N. Impact of the COVID-19 pandemic on cancer diagnosis and resection in a COVID-19 low-burden country: Nationwide registration study in Japan. Eur J Cancer. 2022 Apr;165:113-115. PMID: 35231766

Study Design

Study Type
Others,meta-analysis etc

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Similar Trials